Mass Vaccine and Drug Administration, Bangladesh — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mass Vaccine and Drug Administration, Bangladesh — Stella

Home/Plasmodium Falciparum Malaria/

View on ClinicalTrials.gov

Recruiting

Back to Plasmodium Falciparum Malaria trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Bangladesh

Alikadam Upazila Health Complex, Bāndarban

Lama Upazila Health Complex, Lāma

Key details

Phase

Post-approval study

Sponsor

University of Oxford

Enrollment target

~10,000 participants

Started

February 2025

Primary completion

February 2028

Age range

6 Months and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.